MassDevice.com +5 | The top 5 medtech stories for August 12, 2016

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Bonesupport wins FDA nod for Cerament G trial Bonesupport said it won an investigational device exemption for the Fortify clinical trial of its next-generation Cerament G injectable antibiotic-eluting bone substitute. Cerament G product is an osteoconductive, ceramic substance designed to promote bone healing while preventing bone infection, or osteomyelitis. The resorbable bone graft substitute is designed to remodel into healthy bone within 6-12 months, while preventing colonization of microorganisms by eluting the antibiotic gentamicin. Read more 4. Fractyl touts 1st-in-human data, grabs ex-GI Dynamics medical chief Maggs Fractyl Laboratories today touted the publication of 1st-in-human data from a trial of its Revita duodenal mucosal resurfacing device and said it picked up former GI Dynamics medical chief Dr. David Maggs, who was fired last June, as its new chief medical officer. Results from the study were published in Diabetes Care this month, Fractyl said. Read more 3. Dutch coating supplier’s recall gives Cook Medical another headache A Dutch supplier’...
Source: Mass Device - Category: Medical Equipment Authors: Tags: News Well Plus 5 Source Type: news